The TOMMORROW trial was a phase III global study with 2300+ subjects conducted in 5 countries. VeraSci created appropriately translated and culturally adapted versions of a unique cognitive battery to support the trial’s novel primary endpoint. How did we do it?
- Formal scientific translation that included detailed concept definitions of each measurement and independent forward and back translations
- Gathering regulatory feedback
- Formal in-country pilot testing utilizing review by independent psychologists who were native speakers